BR112015017544A2 - composições que contêm sulfato de condroitina, enzimas proteolíticas e compostos de sulfidrila para melhorar a biodisponibilidade de sulfato de condroitina - Google Patents

composições que contêm sulfato de condroitina, enzimas proteolíticas e compostos de sulfidrila para melhorar a biodisponibilidade de sulfato de condroitina

Info

Publication number
BR112015017544A2
BR112015017544A2 BR112015017544A BR112015017544A BR112015017544A2 BR 112015017544 A2 BR112015017544 A2 BR 112015017544A2 BR 112015017544 A BR112015017544 A BR 112015017544A BR 112015017544 A BR112015017544 A BR 112015017544A BR 112015017544 A2 BR112015017544 A2 BR 112015017544A2
Authority
BR
Brazil
Prior art keywords
chondroitin sulfate
bioavailability
sulfhydryl compounds
improve
combinations
Prior art date
Application number
BR112015017544A
Other languages
English (en)
Other versions
BR112015017544B1 (pt
Inventor
Trentin Antonella
Bianchi Davide
Rossini Mauro
Miraglia Niccolò
Original Assignee
Gnosis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gnosis Spa filed Critical Gnosis Spa
Publication of BR112015017544A2 publication Critical patent/BR112015017544A2/pt
Publication of BR112015017544B1 publication Critical patent/BR112015017544B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/63—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Sustainable Development (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

resumo patente de invenção: "composições que contêm sulfato de condroitina, enzimas proteolíticas e compostos de sulfidrila para melhorar a biodisponibilidade de sulfato de condroitina". a presente invenção refere-se a combinações que compreendem sulfato de condroitina (cs), uma ou mais enzimas ou misturas enzimáticas que possuem atividade proteolítica, e compostos de sulfidrila, para o tratamento e a prevenção da osteodistrofia e de processos inflamatórios agudos e crônicos correlacionados, ou como composições nutracêuticas para a manutenção do bem estar musculosqueletal nos seres humanos e nos animais. a característica das ditas combinações é que elas aumentam a absorção intestinal do cs quando administradas oralmente. o efeito das ditas combinações é exercido em uma ampla gama de pesos moleculares de cs, incluindo amostras de cs com pesos moleculares muito baixos que já possuem uma biodisponibilidade maior do que as amostras com um peso molecular mais elevado. o efeito é exercido em amostras de cs de qualquer origem.
BR112015017544-9A 2013-01-25 2014-01-23 Composições que contêm sulfato de condroitina para melhorar a biodisponibilidade de sulfato de condroitina BR112015017544B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2013A000117 2013-01-25
IT000117A ITMI20130117A1 (it) 2013-01-25 2013-01-25 Composizioni comprendenti condroitin solfato, enzimi proteolitici e composti sulfidrilati capaci di migliorare la biodisponibilita' del condroitin solfato
PCT/EP2014/051308 WO2014114706A1 (en) 2013-01-25 2014-01-23 Compositions containing chondroitin sulphate, proteolytic enzymes and sulphydryl compounds for improving the bioavailability of chondroitin sulphate

Publications (2)

Publication Number Publication Date
BR112015017544A2 true BR112015017544A2 (pt) 2017-07-11
BR112015017544B1 BR112015017544B1 (pt) 2023-04-25

Family

ID=47749928

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015017544-9A BR112015017544B1 (pt) 2013-01-25 2014-01-23 Composições que contêm sulfato de condroitina para melhorar a biodisponibilidade de sulfato de condroitina

Country Status (27)

Country Link
US (1) US20150366978A1 (pt)
EP (1) EP2948160B1 (pt)
JP (1) JP6348123B2 (pt)
KR (1) KR102235577B1 (pt)
CN (1) CN105101985B (pt)
AU (1) AU2014209961B2 (pt)
BR (1) BR112015017544B1 (pt)
CA (1) CA2899129C (pt)
CY (1) CY1118433T1 (pt)
DK (1) DK2948160T3 (pt)
EA (1) EA030130B1 (pt)
ES (1) ES2616017T3 (pt)
GE (1) GEP201706673B (pt)
HR (1) HRP20170198T1 (pt)
HU (1) HUE033162T2 (pt)
IL (1) IL240108B (pt)
IT (1) ITMI20130117A1 (pt)
LT (1) LT2948160T (pt)
MX (1) MX359136B (pt)
NZ (1) NZ710337A (pt)
PH (1) PH12015501474B1 (pt)
PL (1) PL2948160T3 (pt)
PT (1) PT2948160T (pt)
SI (1) SI2948160T1 (pt)
UA (1) UA114941C2 (pt)
WO (1) WO2014114706A1 (pt)
ZA (1) ZA201505322B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106215176A (zh) * 2016-08-22 2016-12-14 安徽瑞达健康产业投资有限公司 一种高效抗炎多酶组合物
CN108741099A (zh) * 2018-06-11 2018-11-06 广州尚天诚品生物科技有限公司 一种有助于关节舒适的营养组合物及其制备方法和应用
KR102231289B1 (ko) * 2018-12-26 2021-03-23 (주)휴온스 고함량 콘드로이틴설페이트 약학 제제 및 이의 제조방법
CN111744018A (zh) * 2019-03-26 2020-10-09 北京福元医药股份有限公司 一种盐酸氨基葡萄糖药物制剂
CN112741272B (zh) * 2021-01-18 2023-02-28 黑龙江中医药大学 一种高含量纳豆激酶的纳豆冻干粉的发酵方法
IT202100030935A1 (it) 2021-12-09 2023-06-09 Fidia Farm Spa Compresse comprendenti condroitin solfato, glucosamina cloridrato e vitamina c per il trattamento di danni cartilaginei, tendinei, ossei

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084482A (en) * 1990-04-10 1992-01-28 The Lithox Corporation Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds
US5679344A (en) 1995-07-20 1997-10-21 Susan K. Williams Glucosamine composition and method
US5840715A (en) * 1995-12-11 1998-11-24 Inholtra Investment Holdings & Trading, N.V. Dietary regimen of nutritional supplements for relief of symptoms of arthritis
US5888514A (en) 1997-05-23 1999-03-30 Weisman; Bernard Natural composition for treating bone or joint inflammation
NZ533078A (en) * 2000-07-31 2006-11-30 Dermal Res Lab Inc Preventing or treating diseases associated with allergies, autoimmunity and adhesion, metastatic and coronary cascades using complex carbohydrates, in particular hyaluronic acid
ITMI20012200A1 (it) * 2001-10-22 2003-04-22 Ibsa Inst Biochimique Sa Processo per la preparazione di condroitin solfati dal polisaccaride k4 e prodotti ottenuti
US20040241256A1 (en) * 2002-12-05 2004-12-02 Seymour Ehrenpreis Medicinal compositions & therapeutic methods
JP4466012B2 (ja) * 2003-08-26 2010-05-26 日油株式会社 腸溶性製剤およびその製造方法
JP2006083151A (ja) * 2004-09-16 2006-03-30 Oriza Yuka Kk 骨粗鬆症予防、改善用組成物
JP5462430B2 (ja) * 2006-01-19 2014-04-02 オリザ油化株式会社 抗炎症剤及び鎮痛剤
US8287858B2 (en) * 2006-08-10 2012-10-16 Jon Barron Proteolytic enzyme formulations
AT504159A1 (de) * 2006-08-16 2008-03-15 Marlyn Nutraceuticals Inc Verwendung von proteasen
US20090110674A1 (en) * 2007-10-24 2009-04-30 Loizou Nicos C Health supplement
RU2381021C2 (ru) * 2007-11-12 2010-02-10 Леонид Леонидович Клопотенко Зубная паста, содержащая липосомы
BR112013027389B1 (pt) 2011-05-12 2021-06-01 Gnosis S.P.A. Processo para o preparo de sal sódico de sulfato de condroitina
MX346787B (es) 2011-05-20 2017-03-31 Gnosis Spa Sulfato de controitina similar al de tiburon y proceso para la preparacion del mismo.
ITMI20120880A1 (it) 2012-05-22 2013-11-23 Gnosis Spa Condroitin 6-solfato biotecnologico a basso peso molecolare dotato di attivita' antiinfiammatoria e antiartritica e suo uso nel trattamento e nella prevenzione dell'osteoartrite

Also Published As

Publication number Publication date
WO2014114706A1 (en) 2014-07-31
JP2016505060A (ja) 2016-02-18
US20150366978A1 (en) 2015-12-24
AU2014209961B2 (en) 2018-05-17
PT2948160T (pt) 2017-02-17
AU2014209961A1 (en) 2015-08-13
LT2948160T (lt) 2017-02-10
CY1118433T1 (el) 2017-06-28
ITMI20130117A1 (it) 2014-07-26
MX359136B (es) 2018-09-14
CA2899129A1 (en) 2014-07-31
PH12015501474A1 (en) 2015-09-21
UA114941C2 (uk) 2017-08-28
KR102235577B1 (ko) 2021-04-06
KR20150111351A (ko) 2015-10-05
GEP201706673B (en) 2017-05-25
CN105101985B (zh) 2018-02-23
PL2948160T3 (pl) 2017-05-31
EP2948160B1 (en) 2016-11-16
CA2899129C (en) 2023-01-17
CN105101985A (zh) 2015-11-25
ZA201505322B (en) 2016-10-26
ES2616017T3 (es) 2017-06-09
EP2948160A1 (en) 2015-12-02
PH12015501474B1 (en) 2015-09-21
MX2015009544A (es) 2015-11-25
EA201591216A1 (ru) 2016-01-29
BR112015017544B1 (pt) 2023-04-25
JP6348123B2 (ja) 2018-06-27
IL240108B (en) 2020-03-31
HRP20170198T1 (hr) 2017-04-07
SI2948160T1 (sl) 2017-02-28
IL240108A0 (en) 2015-09-24
HUE033162T2 (en) 2017-11-28
NZ710337A (en) 2019-04-26
EA030130B1 (ru) 2018-06-29
DK2948160T3 (en) 2017-02-20

Similar Documents

Publication Publication Date Title
BR112015017544A2 (pt) composições que contêm sulfato de condroitina, enzimas proteolíticas e compostos de sulfidrila para melhorar a biodisponibilidade de sulfato de condroitina
BR112016024850A2 (pt) composições e métodos para modulação da expressão 3 semelhante a antiopoietina
BR112015023462A2 (pt) item mastigável comestível para animal
BR112015027281A8 (pt) usos de uma população de nanocarreadores sintéticos que são fixados a imunossupressores e composição compreendendo a referida população de nanocarreadores
BR112016010166A2 (pt) métodos para usar interleucina-10 para tratar doenças e distúrbios
BR112015022514A2 (pt) composições que compreendem selênio e uso das mesmas para o tratamento e prevenção de doença ou condições associadas à disfunção mitocondrial
BR112015028278A2 (pt) processo para a preparação de eritrócitos carregados com uma ou mais substâncias de interesse farmacêutico e eritrócitos assim obtidos
BR112013026447A2 (pt) métodos para a regulação da expressão de gene de sirtuína
BR112015018259A2 (pt) Redução de resposta pró-inflamatória
BR112015023025A2 (pt) composições antimicrobianas e métodos de uso relacionados
BR112012022094A2 (pt) uso de meloxicam para o tratamento de longa duração de distúrbios renais em gatos.
BR112015032572A2 (pt) composições e métodos para melhorar o desempenho durante exercícios
BR112018012952A2 (pt) composições para higiene pessoal
BR112017018272A2 (pt) métodos de tratamento de diarréia e promoção de saúde intestinal em animais não humanos
BR112015031416A2 (pt) métodos para a promoção do desenvolvimento e/ou da saúde neuronal compreendendo a administração de uma combinação de ácido docosa-hexaenoico e ácido alfa-lipoico
PT10615T (pt) Produto cárneo curado em pedaços, em particular fiambre
BR112014027301A2 (pt) composição que compreende um ingrediente sensível
BR112015004813A8 (pt) composição de sabão, método de desinfecção de uma superfície e utilizações de uma composição
BR112012025772A2 (pt) métodos de controle e profilaxia de inflamação e mitigação de condições inflamatórias em animais de estimação
BR112014003545A2 (pt) método para transformar uma refeição
BR112015011462A2 (pt) processos e composições para proteínas fator ix modificadas
BR112022006999A2 (pt) Composição contendo a2-beta-caseína para promover um temperamento melhor em mamíferos jovens
BR112012023894A2 (pt) modificação dos padrões de consumo alimentar em rações para gado de corte
BR112016012233A8 (pt) composições compreendendo cinamaldeído, e seus usos
WO2017220044A3 (zh) 联苯苄唑的药物组合物及其保肝作用

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/01/2014, OBSERVADAS AS CONDICOES LEGAIS